Mymetics Corp (MYMX)

[bow-tie]

The Cancer Consortium
CANCER NEWS & INFORMATION CENTER
SATURDAY, MARCH 5TH, 2022

BLOG
Clinical Trial of GeoVax’s AIDS Vaccine Moves Forward
BY GLOBAL CANCER CONSORTIUM ON JULY 5, 2010

A year ago, we reported on the push to discover an effective AIDS vaccine. As President Obama prepares to release his U.S. AIDS strategy, at least one pharmaceutical company is readying a crucial clinical trial of its vaccine against HIV/AIDS.

Mymetics Corporation is currently testing the first human volunteers in a clinical trial of its preventive AIDS vaccine. The vaccine was well-tolerated by participants. The new study follows an animal trial in which the vaccine demonstrated the ability to prevent infection with the HIV virus. Participants in the human study will be followed for 12 months. The CDC estimates that 1.2 million people in the U.S. have HIV, the virus that causes AIDS.

https://www.thecancerconsortium.org/2010/07/clinical-trial-of-geovaxs-aids-vaccine-moves-forward/